Detalhe da pesquisa
1.
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.
N Engl J Med
; 387(2): 120-131, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658005
2.
Acquired Resistance to KRASG12C Inhibition in Cancer.
N Engl J Med
; 384(25): 2382-2393, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161704
3.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
4.
Lung cancer.
Lancet
; 398(10299): 535-554, 2021 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273294
5.
Phase II Study of Cabozantinib in Patients With Bone Metastasis.
Oncologist
; 27(7): 600-606, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35524758
6.
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
Oncologist
; 27(11): 930-939, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852437
7.
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
Invest New Drugs
; 40(5): 990-1000, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767205
8.
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer.
Int J Cancer
; 147(7): 1963-1969, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32141617
9.
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.
Oncologist
; 25(11): e1691-e1700, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820577
10.
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Invest New Drugs
; 38(5): 1533-1539, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898183
11.
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours.
Br J Cancer
; 119(12): 1471-1476, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425349
12.
Rociletinib in EGFR-mutated non-small-cell lung cancer.
N Engl J Med
; 372(18): 1700-9, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25923550
13.
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
J Natl Compr Canc Netw
; 16(10): 1171-1182, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323087
14.
Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer.
Proc Natl Acad Sci U S A
; 112(5): 1547-52, 2015 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25605928
15.
MET Exon 14 Skipping in Non-Small Cell Lung Cancer.
Oncologist
; 21(4): 481-6, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022036
16.
Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy.
AJR Am J Roentgenol
; 206(5): 987-93, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26934729
17.
Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
Methods
; 83: 118-27, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25913717
18.
Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer.
Proc Natl Acad Sci U S A
; 108(39): 16345-50, 2011 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21911369
19.
Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan.
Cancer Treat Rev
; 125: 102720, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502995
20.
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
Cancer Discov
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564707